|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.820 SEK | +5.57% |
|
+11.62% | +21.79% |
| 07-08 | Mendus Completes First Stage Recruitment for Vididencel Trial | MT |
| 07-08 | Mendus completes recruitment for the first part of the VITAL-CML study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MENDUS AB | Other Biotechnology & Medical Research | +5.57% | +11.62% | +21.79% | -5.01% | -92.07% | 43.4M |  |  | |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
